Related Experiment Videos
The pathogenesis of hyaline arteriolosclerosis
The American Journal of Pathology
|March 1, 1986
Summary
Hyaline arteriolosclerosis involves deposition of inactivated complement fragment C3b (iC3b) bound to hyaluronic acid in arterioles. This process, linked to aging, involves complement pathway activation and may not be preventable.
Area of Science:
- Immunology
- Pathology
- Vascular Biology
Background:
- Hyaline arteriolosclerosis is a common vascular condition with an undetermined pathogenesis.
- The molecular mechanisms underlying hyaline deposition in arterioles remain poorly understood.
Purpose of the Study:
- To elucidate the pathogenesis of hyaline arteriolosclerosis.
- To identify the molecular components and pathways involved in hyaline deposition.
Main Methods:
- Analysis of arteriolar hyaline composition.
- Investigation of complement pathway activation and component deposition.
- Study of interactions between complement fragments, hyaluronic acid, and IgM.
Main Results:
- Inactivated complement fragment C3b (iC3b) bound to hyaluronic acid is a major component of arteriolar hyaline.
- Deposition is driven by alternative complement pathway activation and binding of C3b to hyaluronic acid.
- Hyaline may contain IgM and classical complement pathway components, suggesting activation by autoantibodies.
Conclusions:
- The study identifies iC3b bound to hyaluronic acid as a key element in hyaline arteriolosclerosis pathogenesis.
- The findings suggest a role for complement system dysregulation and aging in the development of this condition.
- Prevention may be challenging due to the essential functions of the alternative complement pathway.